Molecular biology and the staging of prostate cancer

Paolo Marandola, A. Bonghi, H. Jallous, E. Bombardelli, P. Morazzoni, M. Gerardini, D. Tiscione, F. Albergati

Research output: Contribution to journalArticle

Abstract

Cancer of the prostate is still controlled or cured by surgery, radiotherapy, and hormone therapy. The present criteria of complication and prediction are criticized more and more for not being sufficiently reliable, due to the high heterogeneity of prostatic cells. The continuing discoveries of intra-and extracellular mechanisms of the molecular informational network, which allow the continuity or discontinuity of the cell's life, are also related to prostate cancer. The role of androgen receptors is now under close scrutiny, in the light of the knowledge of regulatory genes and their molecular expression. In the near future, a complete study of prostate cancer's DNA is certainly envisaged. Looking forward to the extraordinary applications of molecular biology in this field, this article is aimed at establishing a clear link between the conventional ways of interpreting the clinical expression of prostate cancer and the oncoming applications of genomics and proteomics.

Original languageEnglish
Pages (from-to)294-312
Number of pages19
JournalAnnals of the New York Academy of Sciences
Volume1028
DOIs
Publication statusPublished - 2004

Fingerprint

Molecular biology
Molecular Biology
Prostatic Neoplasms
Radiotherapy
Androgen Receptors
Surgery
Genes
Hormones
DNA
Regulator Genes
Genomics
Proteomics
Prostate Cancer
Cells
Therapeutics

Keywords

  • Androgen receptor
  • Growth factors
  • Predictors
  • Prostate cancer
  • Prostate genes
  • Transcription factors

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Marandola, P., Bonghi, A., Jallous, H., Bombardelli, E., Morazzoni, P., Gerardini, M., ... Albergati, F. (2004). Molecular biology and the staging of prostate cancer. Annals of the New York Academy of Sciences, 1028, 294-312. https://doi.org/10.1196/annals.1322.034

Molecular biology and the staging of prostate cancer. / Marandola, Paolo; Bonghi, A.; Jallous, H.; Bombardelli, E.; Morazzoni, P.; Gerardini, M.; Tiscione, D.; Albergati, F.

In: Annals of the New York Academy of Sciences, Vol. 1028, 2004, p. 294-312.

Research output: Contribution to journalArticle

Marandola, P, Bonghi, A, Jallous, H, Bombardelli, E, Morazzoni, P, Gerardini, M, Tiscione, D & Albergati, F 2004, 'Molecular biology and the staging of prostate cancer', Annals of the New York Academy of Sciences, vol. 1028, pp. 294-312. https://doi.org/10.1196/annals.1322.034
Marandola, Paolo ; Bonghi, A. ; Jallous, H. ; Bombardelli, E. ; Morazzoni, P. ; Gerardini, M. ; Tiscione, D. ; Albergati, F. / Molecular biology and the staging of prostate cancer. In: Annals of the New York Academy of Sciences. 2004 ; Vol. 1028. pp. 294-312.
@article{4931f35844d449bbbbbeb61c0f89ac24,
title = "Molecular biology and the staging of prostate cancer",
abstract = "Cancer of the prostate is still controlled or cured by surgery, radiotherapy, and hormone therapy. The present criteria of complication and prediction are criticized more and more for not being sufficiently reliable, due to the high heterogeneity of prostatic cells. The continuing discoveries of intra-and extracellular mechanisms of the molecular informational network, which allow the continuity or discontinuity of the cell's life, are also related to prostate cancer. The role of androgen receptors is now under close scrutiny, in the light of the knowledge of regulatory genes and their molecular expression. In the near future, a complete study of prostate cancer's DNA is certainly envisaged. Looking forward to the extraordinary applications of molecular biology in this field, this article is aimed at establishing a clear link between the conventional ways of interpreting the clinical expression of prostate cancer and the oncoming applications of genomics and proteomics.",
keywords = "Androgen receptor, Growth factors, Predictors, Prostate cancer, Prostate genes, Transcription factors",
author = "Paolo Marandola and A. Bonghi and H. Jallous and E. Bombardelli and P. Morazzoni and M. Gerardini and D. Tiscione and F. Albergati",
year = "2004",
doi = "10.1196/annals.1322.034",
language = "English",
volume = "1028",
pages = "294--312",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Molecular biology and the staging of prostate cancer

AU - Marandola, Paolo

AU - Bonghi, A.

AU - Jallous, H.

AU - Bombardelli, E.

AU - Morazzoni, P.

AU - Gerardini, M.

AU - Tiscione, D.

AU - Albergati, F.

PY - 2004

Y1 - 2004

N2 - Cancer of the prostate is still controlled or cured by surgery, radiotherapy, and hormone therapy. The present criteria of complication and prediction are criticized more and more for not being sufficiently reliable, due to the high heterogeneity of prostatic cells. The continuing discoveries of intra-and extracellular mechanisms of the molecular informational network, which allow the continuity or discontinuity of the cell's life, are also related to prostate cancer. The role of androgen receptors is now under close scrutiny, in the light of the knowledge of regulatory genes and their molecular expression. In the near future, a complete study of prostate cancer's DNA is certainly envisaged. Looking forward to the extraordinary applications of molecular biology in this field, this article is aimed at establishing a clear link between the conventional ways of interpreting the clinical expression of prostate cancer and the oncoming applications of genomics and proteomics.

AB - Cancer of the prostate is still controlled or cured by surgery, radiotherapy, and hormone therapy. The present criteria of complication and prediction are criticized more and more for not being sufficiently reliable, due to the high heterogeneity of prostatic cells. The continuing discoveries of intra-and extracellular mechanisms of the molecular informational network, which allow the continuity or discontinuity of the cell's life, are also related to prostate cancer. The role of androgen receptors is now under close scrutiny, in the light of the knowledge of regulatory genes and their molecular expression. In the near future, a complete study of prostate cancer's DNA is certainly envisaged. Looking forward to the extraordinary applications of molecular biology in this field, this article is aimed at establishing a clear link between the conventional ways of interpreting the clinical expression of prostate cancer and the oncoming applications of genomics and proteomics.

KW - Androgen receptor

KW - Growth factors

KW - Predictors

KW - Prostate cancer

KW - Prostate genes

KW - Transcription factors

UR - http://www.scopus.com/inward/record.url?scp=14944357682&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=14944357682&partnerID=8YFLogxK

U2 - 10.1196/annals.1322.034

DO - 10.1196/annals.1322.034

M3 - Article

C2 - 15650255

AN - SCOPUS:14944357682

VL - 1028

SP - 294

EP - 312

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -